These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems. Kaiser B, Callas D, Hoppensteadt D, Mallinowska K, Fareed J. Thromb Res; 1994 Mar 01; 73(5):327-35. PubMed ID: 8016817 [Abstract] [Full Text] [Related]
3. Inhibition of fibrinolytic enzymes by thrombin inhibitors. Gilboa N, Villannueva GB, Fenton JW. Enzyme; 1988 Mar 01; 40(2-3):144-8. PubMed ID: 2971531 [Abstract] [Full Text] [Related]
4. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ. Thromb Haemost; 1997 Oct 01; 78(4):1221-7. PubMed ID: 9364988 [Abstract] [Full Text] [Related]
8. A family of arginal thrombin inhibitors related to efegatran. Smith GF, Shuman RT, Craft TJ, Gifford DS, Kurz KD, Jones ND, Chirgadze N, Hermann RB, Coffman WJ, Sandusky GE, Roberts E, Jackson CV. Semin Thromb Hemost; 1996 Oct 01; 22(2):173-83. PubMed ID: 8807715 [Abstract] [Full Text] [Related]
9. Thrombin inhibitory and clot-specific fibrinolytic activities of the urokinase variant, M23 (rscu-PA-40 kDa/Hir). Schneider J, Wnendt S, Saunders D, Heinzel-Wieland R, Wilffert B, Steffens G. Eur J Pharmacol; 1996 Apr 29; 302(1-3):69-77. PubMed ID: 8790994 [Abstract] [Full Text] [Related]
10. Comparative pharmacology of site directed antithrombin agents. Implication in drug development. Callas D, Fareed J. Thromb Haemost; 1995 Jul 29; 74(1):473-81. PubMed ID: 8578509 [Abstract] [Full Text] [Related]
12. Design and synthesis of peptide inhibitors of blood coagulations. Bajusz S, Széll E, Barabás E, Bagdy D. Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Jul 29; 109(1):16-21. PubMed ID: 6177598 [Abstract] [Full Text] [Related]
13. In vitro inhibition of blood coagulation by tripeptide aldehydes--a retrospective screening study focused on the stable D-MePhe-Pro-Arg-H.H2SO4. Bagdy D, Barabás E, Bajusz S, Széll E. Thromb Haemost; 1992 Mar 02; 67(3):325-30. PubMed ID: 1641823 [Abstract] [Full Text] [Related]
15. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa. Ofosu FA, Hirsh J, Esmon CT, Modi GJ, Smith LM, Anvari N, Buchanan MR, Fenton JW, Blajchman MA. Biochem J; 1989 Jan 01; 257(1):143-50. PubMed ID: 2920007 [Abstract] [Full Text] [Related]
16. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates. Odake S, Kam CM, Powers JC. J Enzyme Inhib; 1995 Jan 01; 9(1):17-27. PubMed ID: 8568563 [Abstract] [Full Text] [Related]
17. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy. Brill-Edwards P, Van Ryn-McKenna J, Cai L, Ofosu FA, Buchanan MR. Thromb Haemost; 1992 Oct 05; 68(4):424-7. PubMed ID: 1448774 [Abstract] [Full Text] [Related]
18. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin. Lunven C, Gauffeny C, Lecoffre C, O'Brien DP, Roome NO, Berry CN. Thromb Haemost; 1996 Jan 05; 75(1):154-60. PubMed ID: 8713795 [Abstract] [Full Text] [Related]
19. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy. Callas DD, Fareed J. Thromb Res; 1995 Jun 01; 78(5):457-60. PubMed ID: 7544924 [No Abstract] [Full Text] [Related]
20. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. Mirshahi M, Soria J, Soria C, Faivre R, Lu H, Courtney M, Roitsch C, Tripier D, Caen JP. Blood; 1989 Aug 15; 74(3):1025-30. PubMed ID: 2502207 [Abstract] [Full Text] [Related] Page: [Next] [New Search]